These 10 medtech companies care a lot about research

10. Cochlear

R&D spending: $167,700,000

Percentage of revenues: 12.4%

2018 overall revenue ranking: 53

One of the most significant devices to come out of Cochlear‘s (New South Wales, Australia) R&D department in recent years is the Nucleus 7 sound processor. The Australia-based company touts the Nucleus 7 as the world’s first made-for-smartphone cochlear implant sound processor — compatible with both iOS and Android devices.

A small, behind-the-ear implant sound processor, the Nucleus 7 is available to people who have a Nucleus 24 series implant.

Next >>

Registration is Open for DeviceTalks Boston Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry. REGISTER NOW